Pharmacogenomic Testing Improves Outcomes in MDD Trial - Psych Congress Network

Submitted by Anonymous (not verified) on Mon, 05/07/2018 - 07:00

Pharmacogenomic Testing Improves Outcomes in MDD Trial  Psych Congress NetworkUsing pharmacogenomic testing to guide medication selection for patients with depression improved rates of response and remission, researchers reported.